Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States. The company product pipeline includes Bosakitug (ATI-045), an anti-thymic stromal lymphopoietin...
66 insider purchases on record · latest filing 2024-11-20.
Insiders have also filed 117 sale transactions at ACRS.